ロード中...
Opening the OPK Assay Gatekeeper: Harnessing Multi-Modal Protection by Pneumococcal Vaccines
Pneumococcal vaccine development is driven by the achievement of high activity in a single gatekeeper assay: the bacterial opsonophagocytic killing (OPK) assay. New evidence challenges the dogma that anti-capsular antibodies have only a single function that predicts success. The emerging concept of...
保存先:
| 出版年: | Pathogens |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6963391/ https://ncbi.nlm.nih.gov/pubmed/31652741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pathogens8040203 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|